Alnylam Pharmaceuticals Inc (ALNY)
280.77
-9.93
(-3.42%)
USD |
NASDAQ |
Mar 25, 16:00
280.77
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Shareholders Equity (Quarterly): 67.09M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc | 88.20B |
| Biomarin Pharmaceutical Inc | 5.658B |
| BridgeBio Pharma Inc | -1.468B |
| Regeneron Pharmaceuticals Inc | 29.35B |
| Vertex Pharmaceuticals Inc | 16.41B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.240B |
| Total Liabilities (Quarterly) | 4.173B |
| Debt to Equity Ratio | 15.27 |
| Current Ratio | 2.778 |
| Net Debt Paydown Yield | -0.00% |